Fuse Science launches EnerJel
According to the company, the product featuring transdermal delivery technology reflects the company’s strength and capabilities. Fuse Science CIO and chief marketing officer Aitan Zacharin said until now
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.
Remodulin is approved for the continuous subcutaneous infusion treatment of idiopathic or heritable PAH to improve exercise tolerance and symptoms of the disease. For intravenous Remodulin, United Therapeutics